title: Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections.
abstract: The chemokine receptor CXCR6 has been described on lymphoid cells and is thought to participate in the homing of activated T-cells to non-lymphoid tissue. We now provide evidence that the chemokine receptor CXCR6 is also expressed by activated polymorphonuclear neutrophils (PMN) in vivo: Examination of biopsies derived from patients with pancreatic carcinoma by confocal laser scan microscopy revealed a massive infiltration of PMN that expressed CXCR6, while PMN of the peripheral blood of these patients did not. To answer the question whether CXCR6 expression is a property of infiltrated and activated PMN, leucocytes were collected from patients with localized soft tissue infections in the course of the wound debridement. By cytofluorometry, the majority of these cells were identified as PMN. Up to 50% of these PMN were also positive for CXCR6. Again, PMN from the peripheral blood of these patients were nearly negative for CXCR6, as were PMN of healthy donors. In a series of in vitro experiments, up-regulation of CXCR6 on PMN of healthy donors by a variety of cytokines was tested. So far, a minor, although reproducible, effect of tumour necrosis factor (TNFalpha) was seen: brief exposure with low-dose TNFalpha induced expression of CXCR6 on the surface of PMN. Furthermore, we could show an increased migration of PMN induced by the axis CXCL16 and CXCR6. In summary, our data provide evidence that CXCR6 is not constitutively expressed on PMN, but is up-regulated under inflammatory conditions and mediates migration of CXCR6-positive PMN.
authors.affiliation: Department of Surgery, University of Heidelberg, Heidelberg, Germany.
authors.forename: M M
authors.initials: MM
authors.lastname: Gaida
authors.forename: F
authors.initials: F
authors.lastname: Günther
authors.forename: C
authors.initials: C
authors.lastname: Wagner
authors.forename: H
authors.initials: H
authors.lastname: Friess
authors.forename: N A
authors.initials: NA
authors.lastname: Giese
authors.forename: J
authors.initials: J
authors.lastname: Schmidt
authors.forename: G M
authors.initials: GM
authors.lastname: Hänsch
authors.forename: M N
authors.initials: MN
authors.lastname: Wente
mesh_terms: D000208:Acute Disease; D001424:Bacterial Infections / Q000276:immunology*; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D006801:Humans; D008024:Ligands; D018613:Microscopy, Confocal / Q000379:methods; D009363:Neoplasm Proteins / Q000378:metabolism*; D018375:Neutrophil Activation / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D010019:Osteomyelitis / Q000276:immunology; D010190:Pancreatic Neoplasms / Q000276:immunology*; D016459:Prosthesis-Related Infections / Q000276:immunology; D000075744:Receptors, CXCR6; D019707:Receptors, Chemokine / Q000378:metabolism*; D011991:Receptors, Virus / Q000378:metabolism*; D018461:Soft Tissue Infections / Q000276:immunology; D014407:Tumor Cells, Cultured; D015854:Up-Regulation / Q000276:immunology
chemical_list: C106330:CXCR6 protein, human; D008024:Ligands; D009363:Neoplasm Proteins; D000075744:Receptors, CXCR6; D019707:Receptors, Chemokine; D011991:Receptors, Virus
references.citation: Shock. 2003 Dec;20(6):503-10
references.pmid: 14625473
references.citation: Cytokine Growth Factor Rev. 2005 Dec;16(6):593-609
references.pmid: 16046180
references.citation: Clin Lab. 2005;51(3-4):117-26
references.pmid: 15819166
references.citation: Mol Cancer Res. 2008 Apr;6(4):546-54
references.pmid: 18344492
references.citation: Cancer Sci. 2007 Nov;98(11):1652-8
references.pmid: 17894551
references.citation: Gut. 2002 Feb;50(2):150-2
references.pmid: 11788551
references.citation: J Infect Dis. 2004 Sep 1;190(5):989-97
references.pmid: 15295707
references.citation: Arch Immunol Ther Exp (Warsz). 2005 Nov-Dec;53(6):505-17
references.pmid: 16407783
references.citation: Immunology. 2007 May;121(1):1-14
references.pmid: 17386080
references.citation: J Immunol. 2004 May 15;172(10):6362-72
references.pmid: 15128827
references.citation: J Hepatol. 2003 Jan;38(1):67-75
references.pmid: 12480562
references.citation: Nat Rev Cancer. 2006 Jan;6(1):24-37
references.pmid: 16397525
references.citation: J Immunol. 2004 Jun 1;172(11):7136-43
references.pmid: 15153537
references.citation: J Immunol. 2005 Jan 15;174(2):1055-62
references.pmid: 15634930
references.citation: Br J Cancer. 2007 Oct 22;97(8):1106-15
references.pmid: 17876328
references.citation: J Leukoc Biol. 2006 Oct;80(4):682-4
references.pmid: 16849612
references.citation: J Immunol. 2005 Jan 1;174(1):277-83
references.pmid: 15611250
references.citation: Arthritis Rheum. 2005 Oct;52(10):3004-14
references.pmid: 16200580
references.citation: Clin Exp Allergy. 2005 Dec;35(12):1572-80
references.pmid: 16393323
references.citation: Blood. 2000 May 15;95(10):3032-43
references.pmid: 10807766
references.citation: Mediators Inflamm. 1998;7(1):19-23
references.pmid: 9839694
references.citation: Ann Rheum Dis. 2005 Oct;64(10):1436-42
references.pmid: 15778239
references.citation: N Engl J Med. 2001 Sep 13;345(11):833-5
references.pmid: 11556308
references.citation: J Hematother Stem Cell Res. 2001 Dec;10(6):739-48
references.pmid: 11798500
references.citation: J Clin Pathol. 2004 Jun;57(6):630-6
references.pmid: 15166270
references.citation: Cancer Lett. 2008 Feb 8;259(2):209-17
references.pmid: 18054154
references.citation: Am J Pathol. 2007 May;170(5):1485-96
references.pmid: 17456756
references.citation: Am J Respir Cell Mol Biol. 1999 Apr;20(4):769-76
references.pmid: 10101010
references.citation: Am J Respir Crit Care Med. 2005 Nov 15;172(10):1290-8
references.pmid: 16100013
references.citation: J Leukoc Biol. 2006 Oct;80(4):685-90
references.pmid: 16864602
references.citation: Clin Exp Immunol. 2006 Jan;143(1):70-7
references.pmid: 16367936
references.citation: Blood. 2005 Jul 15;106(2):419-27
references.pmid: 15784733
references.citation: Shock. 2004 Aug;22(2):108-15
references.pmid: 15257082
references.citation: Blood. 2006 Nov 1;108(9):2906-13
references.pmid: 16849637
references.citation: Cell Immunol. 2003 May;223(1):1-12
references.pmid: 12914753
references.citation: N Engl J Med. 2006 Feb 9;354(6):610-21
references.pmid: 16467548
references.citation: Ann N Y Acad Sci. 2006 Aug;1072:276-87
references.pmid: 17057207
references.citation: Eur J Clin Invest. 2004 Feb;34(2):149-55
references.pmid: 14764079
references.citation: Int J Oncol. 2002 Sep;21(3):649-54
references.pmid: 12168113
references.citation: Trends Immunol. 2004 Apr;25(4):201-9
references.pmid: 15039047
references.citation: J Immunol. 2004 Mar 15;172(6):3678-85
references.pmid: 15004171
references.citation: Pancreatology. 2005;5(6):514-29
references.pmid: 16110250
references.citation: Eur J Clin Invest. 1993 Nov;23(11):693-8
references.pmid: 7905828